CIBC Private Wealth Group, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC Private Wealth Group, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$242,000
-31.4%
4,324
-36.6%
0.00%0.0%
Q2 2022$353,000
-28.8%
6,8240.0%0.00%0.0%
Q1 2022$496,000
-40.5%
6,824
-3.2%
0.00%
-50.0%
Q4 2021$833,000
-11.9%
7,0470.0%0.00%0.0%
Q3 2021$945,000
-17.2%
7,0470.0%0.00%
-33.3%
Q2 2021$1,141,000
+28.6%
7,047
-36.3%
0.00%
+50.0%
Q1 2021$887,000
+154.9%
11,055
+72.6%
0.00%
+100.0%
Q4 2020$348,000
+319.3%
6,405
+112.1%
0.00%
Q2 2018$83,000
+1.2%
3,020
-22.3%
0.00%
Q1 2018$82,000
+41.4%
3,889
+29.6%
0.00%
Q4 2017$58,0003,0000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders